OPT-Sciences Corporation (OPST)
OTCMKTS · Delayed Price · Currency is USD
22.75
0.00 (0.00%)
At close: Jan 30, 2026

OPT-Sciences Income Statement

Millions USD. Fiscal year is Dec - Nov.
Fiscal Year
TTMFY 2014FY 2013FY 2012FY 2011FY 2010
Period Ending
Aug '15 Nov '14 Oct '13 Oct '12 Oct '11 Oct '10
7.837.076.226.695.924.9
Revenue Growth (YoY)
23.22%13.73%-6.99%12.95%20.82%0.38%
Cost of Revenue
4.524.613.954.663.963.44
Gross Profit
3.312.462.272.021.961.46
Selling, General & Admin
1.311.221.11.030.90.83
Operating Expenses
1.311.221.11.030.90.83
Operating Income
21.241.170.991.060.63
Other Non Operating Income (Expenses)
0.440.40.390.420.260.08
EBT Excluding Unusual Items
2.451.651.551.411.320.71
Gain (Loss) on Sale of Investments
-00.09-0.070.08-0-0
Pretax Income
2.441.741.481.491.320.7
Income Tax Expense
0.910.630.540.550.460.24
Net Income
1.531.110.940.940.860.46
Net Income to Common
1.531.110.940.940.860.46
Net Income Growth
67.96%18.13%0.48%8.81%87.27%69.49%
Shares Outstanding (Basic)
111111
Shares Outstanding (Diluted)
111111
EPS (Basic)
1.971.441.221.211.110.59
EPS (Diluted)
1.971.441.221.211.110.59
EPS Growth
67.96%18.13%0.48%8.81%87.27%69.49%
Free Cash Flow
1.490.750.650.560.620.77
Free Cash Flow Per Share
1.920.970.830.720.800.99
Gross Margin
42.27%34.82%36.44%30.27%33.08%29.71%
Operating Margin
25.60%17.58%18.76%14.84%17.93%12.80%
Profit Margin
19.55%15.75%15.16%14.04%14.57%9.40%
Free Cash Flow Margin
19.04%10.59%10.38%8.39%10.50%15.74%
EBITDA
2.141.391.311.141.210.79
EBITDA Margin
27.38%19.61%21.12%16.99%20.38%16.05%
D&A For EBITDA
0.140.140.150.140.150.16
EBIT
21.241.170.991.060.63
EBIT Margin
25.60%17.58%18.76%14.84%17.93%12.80%
Effective Tax Rate
37.30%35.99%36.47%36.82%34.78%34.42%
Updated Sep 15, 2015. Source: S&P Global Market Intelligence. Standard template. Financial Sources.